Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra C Walls

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Nature|March 11, 2021
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Science Immunology|November 10, 2022
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccinesJohn E Bowen, Young-Jun Park, Cameron Stewart, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|November 8, 2020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|September 29, 2020
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyLuca Piccoli, Young-Jun Park, M Alejandra Tortorici, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Science Translational Medicine|August 17, 2022
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccinePrabhu S Arunachalam, Yupeng Feng, Usama Ashraf, et al.
Nature|July 19, 2021
Broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Medrxiv : the Preprint Server for Health Sciences|February 23, 2021
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Biorxiv : the Preprint Server for Biology|March 24, 2021
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccinesAlexandra C Walls, Marcos C Miranda, Minh N Pham, et al.
Nature|March 11, 2021
Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodiesDami A Collier, Anna De Marco, Isabella A T M Ferreira, et al.
Science Immunology|November 10, 2022
SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccinesJohn E Bowen, Young-Jun Park, Cameron Stewart, et al.
Biorxiv : the Preprint Server for Biology|August 21, 2020
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|November 8, 2020
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2Alexandra C Walls, Brooke Fiala, Alexandra Schäfer, et al.
Cell|September 29, 2020
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyLuca Piccoli, Young-Jun Park, M Alejandra Tortorici, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2021
Multivalent designed proteins protect against SARS-CoV-2 variants of concernAndrew C Hunt, James Brett Case, Young-Jun Park, et al.
Science Translational Medicine|August 17, 2022
Durable protection against the SARS-CoV-2 Omicron variant is induced by an adjuvanted subunit vaccinePrabhu S Arunachalam, Yupeng Feng, Usama Ashraf, et al.
Nature|July 19, 2021
Broad sarbecovirus neutralization by a human monoclonal antibodyM Alejandra Tortorici, Nadine Czudnochowski, Tyler N Starr, et al.
Pageof 10